...
首页> 外文期刊>The Lancet infectious diseases >Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial
【24h】

Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial

机译:头孢洛林磷铵与头孢曲松钠治疗亚洲社区获得性肺炎的患者:一项随机,对照,双盲,3期,非劣效的嵌套优势试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Ceftriaxone with or without a macrolide antibiotic is a recommended treatment for patients with community-acquired pneumonia requiring hospital admission and intravenous antibiotic treatment. We aimed to assess the efficacy and safety of ceftaroline fosamil compared with ceftriaxone in the treatment of Asian patients admitted to hospital with community-acquired pneumonia.
机译:背景头孢曲松联合或不联合大环内酯类抗生素是需要住院治疗和静脉内抗生素治疗的社区获得性肺炎患者的推荐治疗方法。我们旨在评估与头孢曲松相比,头孢洛林福沙米尔治疗头孢曲松钠在社区获得性肺炎住院的亚洲患者的疗效和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号